Mabaga, Madeleine G.

HRN: 13-79-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
CEFUROXIME 750MG (VIAL)
06/08/2022
06/10/2022
IV
750mg
Q8H
S/P LTCS
Waiting Final Action 
06/08/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/08/2022
06/09/2022
IV
500 Mg
Q8 X 7 Doses
S/p LTCS II Followed By Bilateral Salphingectomy, Thinly Meconuium Stained AF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: